KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) FCF Margin (2016 - 2025)

Historic FCF Margin for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to 12.83%.

  • Bristol Myers Squibb's FCF Margin fell 200700.0% to 12.83% in Q4 2025 from the same period last year, while for Dec 2025 it was 26.65%, marking a year-over-year decrease of 22100.0%. This contributed to the annual value of 26.65% for FY2025, which is 22100.0% down from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's FCF Margin is 12.83%, which was down 200700.0% from 49.02% recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's FCF Margin ranged from a high of 49.02% in Q3 2025 and a low of 12.83% during Q4 2025
  • Its 5-year average for FCF Margin is 28.48%, with a median of 29.77% in 2022.
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 229200bps in 2021, then plummeted by -200700bps in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's FCF Margin stood at 31.18% in 2021, then dropped by -17bps to 25.95% in 2022, then soared by 32bps to 34.17% in 2023, then fell by -4bps to 32.9% in 2024, then plummeted by -61bps to 12.83% in 2025.
  • Its FCF Margin was 12.83% in Q4 2025, compared to 49.02% in Q3 2025 and 28.98% in Q2 2025.